Current Ratio
since 2005
Calculation
Cytokinetics Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2022 | 9.40 | = | 795,186) | ÷ | 84,617) |
| Dec 31, 2021 | 7.45 | = | 535,672) | ÷ | 71,860) |
| Dec 31, 2020 | 15.20 | = | 474,221) | ÷ | 31,199) |
| Dec 31, 2019 | 8.98 | = | 233,752) | ÷ | 26,023) |
| Dec 31, 2018 | 9.36 | = | 207,674) | ÷ | 22,194) |
| Dec 31, 2017 | 8.45 | = | 274,295) | ÷ | 32,444) |
| Dec 31, 2016 | 4.77 | = | 158,633) | ÷ | 33,258) |
| Dec 31, 2015 | 3.57 | = | 113,107) | ÷ | 31,649) |
| Dec 31, 2014 | 5.50 | = | 131,131) | ÷ | 23,855) |
| Dec 31, 2013 | 2.97 | = | 79,338) | ÷ | 26,704) |
| Dec 31, 2012 | 10.76 | = | 76,427) | ÷ | 7,105) |
| Dec 31, 2011 | 11.14 | = | 51,140) | ÷ | 4,592) |
| Dec 31, 2010 | 10.04 | = | 73,498) | ÷ | 7,324) |
| Dec 31, 2009 | 5.79 | = | 116,921) | ÷ | 20,186) |
| Dec 31, 2008 | 2.58 | = | 58,910) | ÷ | 22,877) |
| Dec 31, 2007 | 4.61 | = | 122,016) | ÷ | 26,448) |
| Dec 31, 2006 | 5.82 | = | 153,621) | ÷ | 26,393) |
| Dec 31, 2005 | 7.00 | = | 78,864) | ÷ | 11,264) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial trajectory from 2005 to 2022 reflects a position of substantial short-term liquidity, characterized by current ratios that consistently exceed the conventional benchmark of 2.0. While the liquidity position has remained strong, it has been marked by significant volatility and periodic expansions in the asset base.
- Liquidity Trend Analysis
- The current ratio experienced a notable decline in the early period, dropping from 7.00 in 2005 to a period low of 2.58 in 2008. This was followed by a period of extreme liquidity between 2010 and 2012, where the ratio peaked at 11.14. A sharp contraction occurred in 2013, with the ratio falling to 2.97, before initiating a steady recovery throughout the mid-to-late 2010s.
- Asset and Liability Dynamics
- A significant expansion of the balance sheet is observable starting in 2017. Current assets grew from 207,674 thousand USD in 2018 to 795,186 thousand USD by 2022. During this same period, current liabilities remained relatively contained, only increasing significantly in 2021 and 2022. This divergence contributed to a historical peak in the current ratio of 15.20 in 2020, driven by a surge in current assets to 474,221 thousand USD against liabilities of 31,199 thousand USD.
- Short-Term Solvency Assessment
- The consistently high current ratio suggests a conservative approach to liquidity management and a robust ability to meet short-term obligations. Even during the most constrained periods, such as 2008 and 2013, the ratio remained well above 2.5, indicating that the organization maintained a significant cushion of liquid assets relative to its current debts. The most recent data from 2022 shows a stabilized high liquidity position with a ratio of 9.40.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Cytokinetics Inc., current ratio, long-term trends, comparison to competitors
| Cytokinetics Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 9.40 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 1.22 | 5.06 | 1.48 | 4.83 |
| Dec 31, 2021 | 7.45 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 1.40 | 3.56 | 1.50 | 4.46 |
| Dec 31, 2020 | 15.20 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.35 | 3.63 | 2.13 | 4.33 |
| Dec 31, 2019 | 8.98 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 0.88 | 3.67 | 1.92 | 3.61 |
| Dec 31, 2018 | 9.36 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 1.57 | 4.47 | 1.73 | 3.43 |
| Dec 31, 2017 | 8.45 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | 1.35 | 3.82 | 1.34 | 3.28 |
| Dec 31, 2016 | 4.77 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | 1.25 | 2.56 | 1.44 | 2.31 |
| Dec 31, 2015 | 3.57 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | 1.49 | 3.59 | 1.38 | 2.78 |
| Dec 31, 2014 | 5.50 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | 2.67 | 3.31 | 1.22 | 4.20 |
| Dec 31, 2013 | 2.97 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | 2.41 | 6.01 | 3.16 | 3.99 |
| Dec 31, 2012 | 10.76 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | 2.15 | 7.37 | 2.31 | 3.67 |
| Dec 31, 2011 | 11.14 | — | 4.80 | 1.97 | 1.50 | 1.60 | 5.53 | 2.38 | 2.04 | 2.06 | 4.40 | 1.55 | 3.39 |
| Dec 31, 2010 | 10.04 | — | 3.52 | 1.97 | 1.73 | 2.09 | 2.32 | 2.05 | 1.86 | 2.11 | 3.28 | 2.42 | 2.23 |
| Dec 31, 2009 | 5.79 | — | 4.89 | 2.21 | 1.89 | 1.90 | 2.57 | 1.82 | 1.80 | 1.66 | 4.55 | 2.76 | 4.59 |
| Dec 31, 2008 | 2.58 | — | 3.12 | 2.20 | 1.53 | 0.95 | 3.52 | 1.65 | 1.35 | 1.59 | 6.23 | 2.82 | 4.01 |
| Dec 31, 2007 | 4.61 | — | 2.11 | 1.20 | 1.40 | 2.33 | 4.11 | 1.51 | 1.23 | 2.15 | 2.81 | 1.93 | 2.49 |
| Dec 31, 2006 | 5.82 | — | 1.67 | 1.59 | 1.38 | 1.91 | 3.18 | 1.20 | 1.20 | 2.20 | 10.44 | 1.70 | 3.07 |
| Dec 31, 2005 | 7.00 | — | 2.57 | 1.78 | 1.30 | 1.89 | 6.79 | 2.48 | 1.58 | 1.47 | 8.46 | 1.71 | 3.84 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Cytokinetics Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Cytokinetics Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2022 | 9.40 | 1.30 |
| Dec 31, 2021 | 7.45 | 1.36 |
| Dec 31, 2020 | 15.20 | 1.37 |
| Dec 31, 2019 | 8.98 | 1.66 |
| Dec 31, 2018 | 9.36 | 1.71 |
| Dec 31, 2017 | 8.45 | 1.74 |
| Dec 31, 2016 | 4.77 | 1.91 |
| Dec 31, 2015 | 3.57 | 1.90 |
| Dec 31, 2014 | 5.50 | 2.19 |
| Dec 31, 2013 | 2.97 | 2.17 |
| Dec 31, 2012 | 10.76 | 2.04 |
| Dec 31, 2011 | 11.14 | 2.30 |
| Dec 31, 2010 | 10.04 | 2.14 |
| Dec 31, 2009 | 5.79 | 1.95 |
| Dec 31, 2008 | 2.58 | 1.66 |
| Dec 31, 2007 | 4.61 | 1.74 |
| Dec 31, 2006 | 5.82 | 1.65 |
| Dec 31, 2005 | 7.00 | 1.82 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Cytokinetics Inc., current ratio, long-term trends, comparison to industry (health care)
| Cytokinetics Inc. | Health Care | |
|---|---|---|
| Dec 31, 2022 | 9.40 | 1.23 |
| Dec 31, 2021 | 7.45 | 1.31 |
| Dec 31, 2020 | 15.20 | 1.30 |
| Dec 31, 2019 | 8.98 | 1.48 |
| Dec 31, 2018 | 9.36 | 1.52 |
| Dec 31, 2017 | 8.45 | 1.55 |
| Dec 31, 2016 | 4.77 | 1.73 |
| Dec 31, 2015 | 3.57 | 1.70 |
| Dec 31, 2014 | 5.50 | 1.92 |
| Dec 31, 2013 | 2.97 | 1.96 |
| Dec 31, 2012 | 10.76 | 1.84 |
| Dec 31, 2011 | 11.14 | 1.94 |
| Dec 31, 2010 | 10.04 | 1.81 |
| Dec 31, 2009 | 5.79 | 1.78 |
| Dec 31, 2008 | 2.58 | 1.44 |
| Dec 31, 2007 | 4.61 | 1.53 |
| Dec 31, 2006 | 5.82 | 1.39 |
| Dec 31, 2005 | 7.00 | 1.63 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).